Blue Square Asset Management LLC Increases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Square Asset Management LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,954 shares of the medical equipment provider's stock after purchasing an additional 1,963 shares during the quarter. Intuitive Surgical accounts for approximately 3.5% of Blue Square Asset Management LLC's portfolio, making the stock its 7th largest holding. Blue Square Asset Management LLC's holdings in Intuitive Surgical were worth $6,416,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $25,000. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares in the last quarter. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Global Financial Private Client LLC grew its stake in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Finally, Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 2.7%

Shares of ISRG traded down $13.99 during mid-day trading on Friday, hitting $512.06. The stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,682,083. The company has a market cap of $183.53 billion, a PE ratio of 75.08, a PEG ratio of 5.43 and a beta of 1.64. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The company's fifty day simple moving average is $537.85 and its two-hundred day simple moving average is $536.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the business posted $1.50 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ISRG shares. Barclays lowered their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $592.59.

Insider Buying and Selling

In related news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.